Equillium, Inc. SEC filings EQ
Equillium, Inc. has 465 filings in SEC EDGAR's recent list, going back to Aug 3, 2018. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (unregistered share sale, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Apr 7, 2026 | — |
| S-8 | Employee stock plan registration | Mar 25, 2026 | — |
| S-3 | Shelf registration | Nov 13, 2025 | — |
| 424B5 | Prospectus supplement | Sep 19, 2025 | — |
| S-8 | Employee stock plan registration | Sep 9, 2025 | — |
| S-3 | Shelf registration | Sep 9, 2025 | — |
| S-8 | Employee stock plan registration | Mar 25, 2024 | — |
| 424B5 | Prospectus supplement | Feb 23, 2024 | — |
| 424B5 | Prospectus supplement | Oct 5, 2023 | — |
| S-8 | Employee stock plan registration | Jan 6, 2023 | — |
| S-3 | Shelf registration | Jan 6, 2023 | — |
| 424B3 | Prospectus | Nov 10, 2022 | — |
| S-4/A | Form s-4/a | Nov 9, 2022 | — |
| S-4 | Registration for a merger or exchange | Oct 27, 2022 | — |
| S-8 | Employee stock plan registration | Mar 23, 2022 | — |
| S-8 | Employee stock plan registration | Mar 24, 2021 | — |
| 424B5 | Prospectus supplement | Feb 4, 2021 | — |
| 424B5 | Prospectus supplement | Aug 14, 2020 | — |
| 424B5 | Prospectus supplement | Aug 13, 2020 | — |
| 424B5 | Prospectus supplement | Jul 14, 2020 | — |
| 424B3 | Prospectus | Apr 7, 2020 | — |
| S-1 | Registration statement | Mar 30, 2020 | — |
| S-8 | Employee stock plan registration | Mar 26, 2020 | — |
| S-3 | Shelf registration | Nov 13, 2019 | — |
| S-8 POS | Filing | May 24, 2019 | — |
| S-8 | Employee stock plan registration | Mar 27, 2019 | — |
| S-8 | Employee stock plan registration | Oct 16, 2018 | — |
| 424B4 | Prospectus | Oct 12, 2018 | — |
| S-1/A | Amended registration statement | Oct 2, 2018 | — |
| S-1/A | Amended registration statement | Sep 28, 2018 | — |
| S-1 | Registration statement | Sep 17, 2018 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EQ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1746466
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.